BD has shared a notification providing product security information and recommendations related to a security vulnerability found within specified versions of its BD BodyGuard infusion pumps.
Becton Dickinson reported a vulnerability in its BodyGuard pumps to the U.S. Cybersecurity and Infrastructure Security Agency (CISA), which posted a report on the problem.
An attacker with physical access to the device and specialized equipment and knowledge could exploit the vulnerability to change the configuration settings or disable the pump, according to the agency.
The vulnerability scored 5.3 on the 10-point risk scale. The medium score on the risk scale reflects the need for physical access and low probability of harm.
Read the full article at MedTech Dive.
